Mixed Methods Study to Assess Family Members Unmet Needs in an Oncology Setting
NCT ID: NCT06142071
Last Updated: 2024-07-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
50 participants
OBSERVATIONAL
2024-01-08
2024-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1. The proportion of family members of cancer patients who say they need more support
2. What support family members feel would be beneficial
Information about patients' cancer diagnosis and treatment will be collected from their medical notes.
Participating family members will be asked to complete a telephone questionnaire. Selected family members may also be asked to participate in an optional follow-up interview.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Study of Family Caregivers' Needs, Burden of Care and Quality of Life Over the Course of a Cancer Illness
NCT03081312
Support Needs and Preferences of Family Caregivers of Lung Cancer Patients
NCT00967083
A Multi-center Investigation of Family Health.
NCT06433349
An Exploratory Study of Caregiver Burden Among Family Caregivers of Patients With Cancer
NCT03069105
Improving Survivorship Among Minority Cancer Dyads
NCT04685551
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Family members may want more information or advice, or may benefit from emotional support themselves. The study aims to identify any gaps in the current support provided to family members so that services can be improved in the future.
Oncology patients in Singleton Hospital, Swansea will be asked by their oncology team to identify one or more family members to participate in the study. If a family member agrees to participate in the study, the research team will call them to complete a telephone questionnaire. The questionnaire should take less than 20 minutes and asks them some general questions (e.g. age, gender) and some questions about how they are feeling, what support services they find helpful and what additional support they feel would be beneficial.
Data regarding participating patients' cancer diagnosis and treatment will be collected from their medical notes.
After the questionnaire data has been analysed, optional follow-up interviews will be conducted with some family members to explore any issues identified in greater detail.
Patients and family members will be recruited during a 6 month recruitment period and all responses will be anonymised.
This is a pilot study which will not change the current support provided to family members, although they may be directed to existing services if appropriate. Patients' treatment will not be changed in any way.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Telephone questionnaire
Telephone questionnaire, which includes questions on participant's demographics, anxiety/depression scores, what support they find helpful and what additional support they feel would be beneficial
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* able to identify at least one family member who may be willing to participate in the study
\- a family member of a patient diagnosed with a solid organ malignancy under the care of the oncology team
Exclusion Criteria
* the patient's treating oncologist's opinion is that participating in the study would cause severe distress to the patient or their family
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Swansea University
OTHER
Swansea Bay University Health Board
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sing Yu Moorcraft
Role: PRINCIPAL_INVESTIGATOR
Swansea Bay University Health Board
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
South West Wales Cancer Centre
Swansea, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
331660
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.